N
AKRO

Natixis’s Akero Therapeutics AKRO Stock Holding History

Natixis’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52,879
Closed -$2.51M – 1117
2025
Q3 		$2.51M Buy
+52,879
New +$2.56M 0.01% 533

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Natixis's AKRO Position: Q4 2025 in Review

Natixis sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 52,879 shares — an estimated $2.51M sold.

Natixis first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $2.51M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Natixis reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Natixis sold 52,879 Akero Therapeutics shares in Q4 2025, an estimated $2.51M.
  • Natixis first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • Natixis's Akero Therapeutics position peaked at $2.51M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Natixis's 13F filing for Q4 2025, filed 13 Feb 2026.